TI
ADMS

Trexquant Investment’s Adamas Pharmaceuticals ADMS Stock Holding History

Trexquant Investment’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-10,533
Closed -$272K – 1285
2018
Q2 		$272K Buy
+10,533
New +$292K 0.02% 710
2017
Q2 		– Sell
-16,372
Closed -$287K – 1298
2017
Q1 		$287K Buy
+16,372
New +$279K 0.04% 780
2016
Q3 		– Sell
-36,617
Closed -$554K – 1093
2016
Q2 		$554K Sell
36,617
-31,383
-46% -$517K 0.07% 441
2016
Q1 		$983K Buy
+68,000
New +$1.15M 0.12% 304
2015
Q4 		– Sell
-11,600
Closed -$194K – 1360
2015
Q3 		$194K Buy
+11,600
New +$264K 0.02% 980

Other funds holding ADMS

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BWCA
Brenner West Capital Advisors New York $804M AUM 16.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Trexquant Investment's ADMS Position: Q3 2018 in Review

Trexquant Investment sold out of Adamas Pharmaceuticals (ADMS) in Q3 2018, closing a stake of 10,533 shares — an estimated $272K sold.

Trexquant Investment first reported a position in ADMS in Q3 2015 and held it in 5 quarters. The position peaked at $983K in Q1 2016. 125 funds tracked by Wall St. Rank hold ADMS as of Q3 2018.

  • Trexquant Investment reported no remaining Adamas Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • Trexquant Investment sold 10,533 Adamas Pharmaceuticals shares in Q3 2018, an estimated $272K.
  • Trexquant Investment first reported a position in Adamas Pharmaceuticals in Q3 2015 and held it in 5 quarters.
  • Trexquant Investment's Adamas Pharmaceuticals position peaked at $983K in Q1 2016.
  • 125 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q3 2018.

Based on Trexquant Investment's 13F filing for Q3 2018, filed 9 Nov 2018.